Novomedopa
Brand names,
Novomedopa
Analogs
Novomedopa
Brand Names Mixture
Novomedopa
Chemical_Formula
C56H71N9O23S
Novomedopa
RX_link
http://www.rxlist.com/cgi/generic4/mycamine.htm
Novomedopa
fda sheet
Novomedopa
msds (material safety sheet)
Novomedopa
Synthesis Reference
No information avaliable
Novomedopa
Molecular Weight
1270.28 g/mol
Novomedopa
Melting Point
No information avaliable
Novomedopa
H2O Solubility
Freely soluble as sodium salt (> 200mg/mL)
Novomedopa
State
Solid
Novomedopa
LogP
No information avaliable
Novomedopa
Dosage Forms
Powder for solution (for injection)
Novomedopa
Indication
For use in the treatment of patients with esophageal candidiasis and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.
Novomedopa
Pharmacology
Formerly known as FK463, micafungin is a novel antifungal agent. It is a glucan synthesis inhibitor of the echinocandin structural class. The U.S. Food and Drug Administration approved micafungin in March 2005. Micafungin inhibits an enzyme essential for fungal cell-wall synthesis and is fungicidal (lethal) for Candida. Micafungin can be used concomitantly with a variety of other drugs, including the HIV protease inhibitor ritonavir and the transplant medications cyclosporine and tacrolimus.
Novomedopa
Absorption
No information avaliable
Novomedopa
side effects and Toxicity
Intravenous LD50 in rats is 125mg/kg. In dogs it is >200mg/kg. No cases of overdosage have been reported. Repeated daily doses up to 8 mg/kg (maximum total dose of 896 mg) in adult patients have been administered in clinical trials with no reported dose-limiting toxicity. The minimum lethal dose is 125 mg/kg in rats, equivalent to 8.1 times the recommended human clinical dose for esophageal candidiasis based on body surface area comparisons.
Novomedopa
Patient Information
No information avaliable
Novomedopa
Organisms Affected
Aspergillis, Candida and other fungi